Cargando…
Beta-blockers provide a differential survival benefit in patients with coronary artery disease undergoing contemporary post-percutaneous coronary intervention management
Beta-adrenergic receptor blockers are used in patients with coronary artery disease (CAD) to reduce the harmful effects of excessive adrenergic activation on the heart. However, there is limited evidence regarding the benefit of beta-blockers in the context of contemporary management following percu...
Autores principales: | Lee, Pil Hyung, Park, Gyung-Min, Han, Seungbong, Kim, Yong-Giun, Lee, Jong-Young, Roh, Jae-Hyung, Lee, Jae-Hwan, Kim, Young-Hak, Lee, Seung-Whan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7746699/ https://www.ncbi.nlm.nih.gov/pubmed/33335231 http://dx.doi.org/10.1038/s41598-020-79214-0 |
Ejemplares similares
-
Effect of Beta Blockers and Renin–Angiotensin System Inhibitors on Survival in Patients With Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention
por: Lee, Pil Hyung, et al.
Publicado: (2016) -
Sex-related impacts on clinical outcomes after percutaneous coronary intervention
por: Park, Hyun Woo, et al.
Publicado: (2020) -
Pre-existing depression in patients with coronary artery disease undergoing percutaneous coronary intervention
por: Park, Jangho, et al.
Publicado: (2021) -
Trends, Characteristics, and Clinical Outcomes of Patients Undergoing Percutaneous Coronary Intervention in Korea between 2011 and 2015
por: Han, Seungbong, et al.
Publicado: (2018) -
Effect of atrial fibrillation in Asian patients undergoing percutaneous coronary intervention with drug-eluting stents for stable coronary artery disease: Results from a Korean nationwide study
por: Han, Seungbong, et al.
Publicado: (2018)